...November. Mummenbrauer expects the series A round -- which saw participation from VIB, UCB Ventures, SFPI-FPIM...
...Number of employees: 3 Funds raised: €23 million ($26.9 million) Investors: Fund+, VIB, UCB Ventures, SFPI-FPIM...
...von Willebrand factor Danielle Golovin, Staff Writer Cablivi, anti-vWF Nanobody, caplacizumab (ALX-0081/ALX-0681) Flanders Institute for Biotechnology (VIB) UCB Ventures SFPI-FPIM V-Bio...

...MaSTherCell’s investors include Great Point Partners, CDMO Orgenesis Inc. (NASDAQ:ORGS) and Belgian government investment company SFPI-FPIM...

...Partners, Shinhan-Cognitive Start-up Fund, UTC 2019 Bioventurefund, SRIW and Sambrinvest. Also participating were existing investors SFPI-FPIM...

...repair Cancer iTeos Therapeutics S.A. $75.0 Series B HBM Partners, 6 Dimensions Capital, Curative Ventures, SFPI-FPIM...

...S.A. until October 2016. Investors in its €18 million ($19.8 million) series B round included SFPI-FPIM...

...million ($81 million). LPs include the European Investment Fund (EIF), PMV-ARKimedes, Korys, KU Leuven, Gimv, SFPI-FPIM...

...EUR 125 million ($136.1 million), exceeding its EUR 100 million ($108.9 million) target. Investors included SFPI-FPIM...

...disorders Universite catholique de Louvain Gene/cell therapy; musculoskeletal Epimede; Fund+; Integrale; New Science Ventures; Nivelinvest; SFPI-FPIM...

...Belgium Business: Proteomics Date completed: 2015-10-02 Type: Venture financing Raised: EUR16 million ($18 million) Investors: SFPI-FPIM...

...Brussels, Belgium) raised EUR 16 million in a series B round co-led by new investors SFPI-FPIM...